Current and future drug therapies for claudication.

Abstract

The primary objectives of claudication treatment are to reduce cardiovascular mortality and improve walking ability. Patients with claudication have 60% mortality over 10 years, with most deaths due to myocardial infarction and stroke. Aggressive risk-factor modification is required in all these patients, particularly smoking cessation, lipid modification… (More)

Topics

Cite this paper

@article{Hiatt1997CurrentAF, title={Current and future drug therapies for claudication.}, author={Willie Hiatt}, journal={Vascular medicine}, year={1997}, volume={2 3}, pages={257-62} }